ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,838, issued on May 19, was assigned to eGenesis Inc. (Cambridge, Mass.).
"Cells, tissues, organs, and animals having one or more modified genes for enhanced xenograft survival and tolerance" was invented by Jacob Layer (Cambridge, Mass.), Wenning Qin (Cambridge, Mass.), Yinan Kan (Cambridge, Mass.), Juliet Crabtree (Cambridge, Mass.), Michele Youd (Cambridge, Mass.), David Heja (Cambridge, Mass.), David Angeles Albores (Cambridge, Mass.), Ranjith Anand (Cambridge, Mass.), Paola Perrat (Cambridge, Mass.), Russell Ernst (Cambridge, Mass.) and Violette Paragas (Cambridge, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relate...